(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

Dear Susan, While osteoporosis is much more common in adults age 60 and older, it can strike younger people too. In fact, ...

Amgen shares dropped over 7% Tuesday after bone density data from an early-stage trial of its weight loss drug, MariTide, ...

Cantor Fitzgerald tells investors that MariTide’s Phase 1 data includes “a big surprise” as the supplemental appendix file ...

NASA officials quickly refuted those claims, saying Williams and the other three agency astronauts currently living on the ...

O rthopedic doctors have a bone to pick with all the people who forget they’re carrying a very important skeleton around ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

FRAX has been validated for fracture risk assessment for patients with cancer, with HRs indicating an association between ...

Dear Savvy Senior, Can a person in their early fifties have osteoporosis? When I fell and broke my wrist last winter, the ...

The condition is becoming more common due to the United States' aging population and lifestyle issues, particularly smoking, ...